However, another study showed increased leptin levels in metabolic syndrome as well as patients with spondyloarthritis but not in patients with RA after one year of treatment with DMARD [63], and a decrease in disease activity correlated with decreased leptin levels could be observed in this study. Here, LEP is linked to metabolic syndrome.